Gotenba, Japan

Hitoshi Yoshino

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 13.5

ph-index = 3

Forward Citations = 67(Granted Patents)


Location History:

  • Gotenba, JP (2007 - 2013)
  • Shizuoka, JP (2020 - 2023)

Company Filing History:


Years Active: 2007-2025

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: Hitoshi Yoshino: Innovator in Pharmaceutical Chemistry

Introduction

Hitoshi Yoshino is a prominent inventor based in Gotenba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating diabetes and obesity. With a total of 9 patents to his name, Yoshino's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

One of Yoshino's latest patents is a pyrazolopyridine derivative that exhibits a GLP-1 receptor agonist effect. This invention provides a compound characterized by a specific structure where the indole ring and the pyrazolopyridine structure are connected through a substituent. The patent also covers salts and solvates of the compound, which can be utilized as preventative or therapeutic agents for non-insulin-dependent diabetes mellitus (Type 2 diabetes) and obesity.

Career Highlights

Throughout his career, Hitoshi Yoshino has worked with notable companies, including Chugai Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Yoshino has collaborated with several talented individuals in his field, including Takuya Shiraishi and Satoshi Tsuchiya. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Hitoshi Yoshino's innovative work in pharmaceutical chemistry, particularly in developing treatments for diabetes and obesity, showcases his dedication to improving health outcomes. His contributions through his patents reflect a commitment to scientific advancement and the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…